FIELD: medicine.
SUBSTANCE: present invention concerns medical products, particularly a nasal pharmaceutical composition for treating or relieving the rhinitis symptoms, containing aqueous suspension of solid particles of fluticasone with the following particle size distribution profile: approximately 10% of particles are smaller than 0.90 microns; approximately 25% of particles are smaller than 1.6 microns; approximately 50% of particles are smaller than 3.2 microns; approximately 75% of particles are smaller than 6.2 microns; approximately 90% of particles are smaller than 10.0 micron; where the composition is available for intranasal introduction in nasal mucosa. Besides the invention relates to the methods of treating said diseases.
EFFECT: composition provides improved therapeutic efficiency at a small dose of fluticasone.
58 cl, 4 dwg, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NASAL PHARMACEUTICAL COMPOSITIONS AND METHODS OF APPLICATION THEREOF | 2004 |
|
RU2373925C2 |
| COMBINATION OF LEVOCABASTINE AND FLUTICASONE FUROATE FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC CONDITIONS | 2013 |
|
RU2652352C2 |
| COMPOSITIONS AND METHODS OF TREATING RHINOSINUSITIS | 2004 |
|
RU2410083C2 |
| TREATMENT OF ALLERGIC RHINITIS IN PEDIATRIC CATEGORY USING A COMBINATION OF MOMETASONE AND OLOPATADINE | 2019 |
|
RU2798030C2 |
| TREATMENT OF ALLERGIC RHINITIS USING A COMBINATION OF MOMETASONE AND OLOPATADIN | 2014 |
|
RU2799761C2 |
| TREATMENT OF ALLERGIC RHINITIS USING COMBINATION OF MOMETASONE AND OLOPATADINE | 2014 |
|
RU2686670C2 |
| AXELASTIN AND STEROIDS COMBINATION | 2003 |
|
RU2361593C2 |
| AQUEOUS AEROSOL PREPARATION | 2004 |
|
RU2363449C2 |
| IMPROVEMENT OF NASAL COMPOSITIONS AND METHOD FOR THEIR USE | 2015 |
|
RU2781144C2 |
| METHODS OF TREATING ALLERGIC DISEASES | 2011 |
|
RU2587061C2 |
